TFC recently purchase 2 pharmaceutical development and marketing companies in Santalis and Viroxis. There has been no information forthcoming from TFC to help shareholders understand the risks of these acquisition.
Development of drugs can be an expensive enterprise.
How much TFC cash will these companies burn through before making money?
How much TFC management focus and energy will need to be directed at them to the detriment of the core business.
- Forums
- ASX - By Stock
- What are the negatives?
TFC recently purchase 2 pharmaceutical development and marketing...
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add TFC (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, MD & CEO
Anthony Noble
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online